In the case of the GLP-1, such as O-Pick, it may cause blindness to be created. New articles this week explained to many people who developed the eyes shortly after they began to take semaglutide and similar drugs.
Eye doctor at Utah University, health, and other places, published research, which describes the case of many vision complications, may be linked to obesity and drugs. These diabetes The drugs are linked to three different eyes, all of which can lead to blindness. But as the doctor warns the case alone does not specify that the GLP-1 drug can cause these problems and need more research to understand clearly what happened.
Other research introduced the connection between GLP-1, such as semaglutide (active ingredients used in OZEMPIC and Wegovy) and Tirzepatide (Mounjaro and Zepbound) and higher risk of eye problems.
In the summer last year, researchers at the special eye hospital Published The study found that patients who specify semaglutide tend to develop Neuropathy Iterior Ischemic Optic (Nion) that is not caused by the loss of blood flow to the optic nerve. In December, Public Health officials in Denmark Call For the European Union to check the possible links during the officially use the GLP-1 and Nion after the Danish educated.
This latest paper Published Last month in OphthalmologyPresent the series of nine cases Seven cases, including people with experience after starting the GLP-1; One person develops papillitis types of inflammation of the optic nerve; And the maculopathy in the middle pacentral developed. Maculopathy type of blood vessels that have been damaged in Macula, the central area of the retina that helps to see sharp vision. In many cases, the loss of people's vision has been resolved or stopped after they stopped using the drug, even if there were a few treatment without delay.
The researchers are fast in observing these cases, not smoking guns for GLP-1 medication, causing problems with these eyes.
“In this case study, it is impossible to check that there is a reasoning between these drugs and an ophthalmologist report.” They wrote and if there is a linking, such causes may be complicated. More than the first overall picture
Everyone, but there are people involved in people with the history of type 2 diabetes, which is a symptom that has continuously increased blood sugar. Researchers know that some cases of Papillitis are tied to the rapid reduction of people's blood sugar, and they also guess, may be true for some cases of the NION. In other words, GLP-1 may create. To achieve these cases, at least in some cases, indirectly reducing blood sugar levels, instead of the direct toxic substance of the drug itself. But there may be other trigger to consider Some cells in the optic nerve have a GLP-1 receiver. For example, it is another way that these drugs are harmful to the function of the eyes.
Regardless of the method, the researchers say that there is more work to study this link. These things are rare, even a slightly increased risk can affect many people because these drugs are popular around the world. And loosening the mechanism behind this connection may lead to better care If these conditions are caused by the blood sugar levels quickly decreased as the researchers believe that we can protect the future patients, just suggest the GLP-1 treatment curriculum in patients with high risk. (In general, the treatment with GLP-1 in an increase in the increased amount.) The doctor hopes that their discovery will promote the perception of possible links between colleagues. Their work
“More studies are needed to test our hypothesis. However, this is an important problem for an ophthalmologist, while we check the use of these drugs and how to communicate with our patients about them. ” Huh Moran in a statement from the university